“Currently, 35 to 40 hospitals across the country have joined hands with ImmunoACT for CAR-T cell therapy,” said Professor Rahul Purwar, Founder and CEO Chairman of IIT Bombay-incubated company.
NL Correspondent Jammu Tawi: Amrita Hospital, Faridabad, in collaboration with ImmunoACT which is an IIT-Bombay incubated company, has introduced CAR T-cell (Chimeric antigen receptor) therapy for certain cancer patients, which is considered a significant breakthrough in B cell lymphoma and leukemia treatment, with promising results in relapsed and refractory patients. Four patients of B-cell Lymphoma
FARIDABAD: Amrita Hospital in Faridabad has introduced CAR T-cell (Chimeric antigen receptor) therapy for certain cancer patients, which is considered a significant breakthrough in B cell lymphoma and leukemia treatment, with promising results
ImmunoACT announces the approval of India s first CAR-T cell therapy, NexCAR19 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.